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Abstract
Summary As fracture risk assessment is a basis for treatment
decisions, accurate risk assessments on bone mineral density
(BMD) reports are important. Over 50 % of sampled BMD
reports for Ontarians with fracture histories underestimated
fracture risk by a single category. Risk assessments in Ontario
may not accurately inform treatment recommendations.
Introduction The shifting emphasis on fracture risk assess-
ment as a basis for treatment recommendations highlights
the importance of ensuring that accurate fracture risk assess-
ments are present on reading specialists’ BMD reports. This
study seeks to determine the accuracy of fracture risk assess-
ments on a sample of BMD reports from 2008 for individ-
uals with a history of fracture and produced by a broad cross
section of Ontario’s imaging laboratories.
Methods Forty-eight BMD reports for individuals with docu-
mented history of fragility fracture were collected as part of a
cluster randomized trial. To compute fracture risk, risk factors,
and BMD T-scores from reports were abstracted using a
standardized template and compared to the assessments on
the reports. Cohen’s kappa was used to score agreement
between the research team and the reading specialists.
Results The weighted kappa was 0.21, indicating agreement
to be at the margin of “poor to fair.” More than 50 % of the
time, reported fracture risks did not reflect fracture history
and were therefore underestimated by a single category.
Over 30 % of the reports containing a “low” fracture risk
assessment were assessed as “moderate” fracture risk by the
research team, given fracture history. Over 20 % of the
reports with a “moderate” fracture risk were assessed as
“high” by the research team, given fracture history.
Conclusions This study highlights the high prevalence of
fracture risk assessments that are underestimated. This has
implications in terms of fracture risk categorization that can
negatively affect subsequent follow-up care and treatment
recommendations.
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Introduction
Although reduced bone mass is an important and easily
quantifiable measurement, studies have shown that most
fractures occur in individuals with bone mineral density
(BMD) above a T-score of −2.5 [1–5]. As a result, the
emphasis of recent clinical practice guidelines for osteopo-
rosis has shifted from BMD to fracture risk [6, 7]. In fact,
new reporting guidelines base treatment recommendations
on assessments of fracture risk, as opposed to diagnosis of
osteoporosis based on BMD T-scores alone [8].
Measures of fracture risk, such as the Fracture Risk
Assessment tool from the World Health Organization
(WHO) [9] and the Canadian Association of Radiologists
and Osteoporosis Canada (CAROC) tool [10], have been
designed to predict an individual’s 10-year fracture risk. In
2005, the Canadian Association of Radiologists (CAR) rec-
ommended fracture risk assessments to be included on all
reading specialists’ (typically radiologists’) BMD reports
[11]. Because clinical practice guidelines recommend that
these assessments be used to guide treatment decisions, it is
important to ensure not only that reports contain the assess-
ments, but also that these assessments are accurate. Howev-
er, an accurate fracture risk assessment may be difficult for a
reading specialist to produce as it depends on information
beyond BMD T-score, such as fracture history. Such clinical
information may be difficult for a specialist to access and is
therefore subject to omission on reports [9, 10].
The primary objective of this study is to examine the
accuracy of fracture risk assessments on BMD reports from
a wide range of imaging laboratories for individuals with a
history of fragility fracture in non-urban areas in the prov-
ince of Ontario, Canada. The BMD reports studied were
gathered as part of a cluster randomized trial in 2008. As a
result, assessment accuracy is defined as concordance be-
tween the fracture risk stated on the BMD report and assess-
ments produced by our research team using (1) knowledge
of fracture history and (2) the assessment methodology
sanctioned by CAR in 2005 [11] and current as of 2008. It
should be noted, however, that Osteoporosis Canada has
since recommended significant methodological changes for
fracture risk assessment in their 2011 Guidelines [8]. Sec-
ondary objectives were to determine if the reports followed
the 2005 CAR standard for diagnostic categorization and
were in the recommended report format.
Methods
Study design
The BMD reports examined in this study were collected as
part of a cluster randomized trial evaluating the effect of a
centralized coordinator who identifies and follows up with
fracture patients treated in small non-urban community hos-
pitals and their primary care physicians about osteoporosis
care, including referral for BMD testing and pharmacologic
treatment [12].
Setting and participants
Hospitals without a dedicated fracture clinic and that treated
more than 60 fracture patients per year in their emergency
department (ED) were eligible (n054) for the trial. Ethical
approval was obtained from the Research Ethics Board of
the Toronto Rehabilitation Institute and each of the partici-
pating sites.
Emergency department records provided through the Na-
tional Ambulatory Care Reporting System database at each
hospital were used to identify all new cases of fracture.
Records were selected for individuals over 40 years of age
who sustained fractures at the hip, forearm, wrist, rib(s),
sternum, thoracic and lumbar spine, shoulder and upper
arm, pelvis, lower leg, and ankle. Patients with “cause of
injury” codes indicating that the fracture was not due to
major trauma (e.g., traffic accidents), who were residing in
a nursing home, or with fractures that occurred more than
3 months between the time of their initial ED visit and
preparation of the list for the centralized coordinator were
excluded.
Patients were recruited by telephone between January
and July 2008 and further screened with the following
exclusion criteria: unable to contact, died, in long-term care,
cognitive or hearing impairment, lived outside the region,
and previously screened by an Osteoporosis Strategy coor-
dinator at another hospital [13]. During screening, all reports
of fragility fracture were verified by a physical therapist who
confirmed that the patient had had a low-trauma fracture.
Data were collected at baseline and follow-up at 6 months.
All patients who had a BMD test scheduled or performed by
the 6-month follow-up call were asked permission to allow
the researchers to contact their family physician to obtain a
copy of the report. Bone mineral density test reports were
gathered by fax from consenting patients’ family physicians.
Data abstraction
Each BMD report was reviewed by two members of the
research team, and data were abstracted using a standardized
template that included risk factors used by the CAROC
fracture risk assessment tool.
Fracture risk assessment review
The CAROC 10-year fracture risk assessment tool incorpo-
rates BMD information (lowest T-score from the lumbar
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spine (L2–L4), femoral neck, and total hip), age, sex, frac-
ture history, and glucocorticoid use [11]. Calculation of
fracture risk is not recommended for individuals under age
50 and for individuals age 50 and older; risk reporting is
recommended regardless of osteoporosis treatment status
[8]. It should be noted, however, that in 2005, some ambi-
guity existed as to whether risk should be reported for
patients on treatment; risk reporting for treated patients is
not explicitly outlined by Siminoski and colleagues [11].
The lowest T-score on reports from the spine, total hip, or
femoral neck, in combination with each patient’s age and
sex, was used to calculate baseline 10-year absolute fracture
risk. This is in accordance with CAR’s 2005 recommenda-
tions, which state: “the lowest T-score from the spine, the
total hip, the trochanter and the femoral neck” is to be used
to calculate baseline risk, but add that assessments are
“based on published data for only the femoral neck” [11].
Osteoporosis Canada’s 2011 Guidelines have since recom-
mended only femoral neck T-scores be used as the basis for
fracture risk assessment [8]. As all patients in this study
sustained a recent fracture, all calculated baseline fracture
risk assessments were then elevated one category of risk, as
per instructions outlined by Siminoski and colleagues [11].
For example, those with “low” fracture risk based on BMD
T-score, age, and sex were assigned to the “moderate” risk
category, and those with “moderate” fracture risk were
assigned to the “high” risk category. Patients with recent
prolonged systemic glucocorticoid use, as evidenced by
information on reports, were placed in the “high” fracture
risk category regardless of BMD T-score because they also
had fragility fracture.
Assessments made by the research team and using the
CAROC heuristics were then compared to the fracture risk
assessments presented in the reading specialists’ reports. In
the instances where several competing fracture risks were
assigned to different imaged regions (e.g., the lumbar spine
versus total hip) and the specialist additionally indicated an
overall fracture risk, the overall risk assessment only was
compared to the assessment made by the research team.
Concordance between assessments made by reading spe-
cialists and the research team was measured using Cohen’s
kappa [14, 15]. Raw kappa statistics were calculated as well
as linearly weighted kappas, with weights structured to
penalize disagreements separated by two categories of risk
more than those separated by one category.
Diagnostic categorization review
Collected reports were also reviewed to determine if
CAR’s standards of diagnostic categorization, published in
2005 [11], were used on the BMD reports. The CAR’s
categorizations differ from the WHO’s in that they distin-
guish post-menopausal women (“normal”, “osteopenia,”
and “osteoporosis”) from pre-menopausal women and men
(“normal” or “reduced bone density”). To assign CAR di-
agnostic categorizations, the research team abstracted the
gender, age, and lowest T-score results from the following
sites: lumbar spine, total hip, trochanter, and femoral neck.
These data as well as menopausal status were then used to
categorize participants according to CAR criteria. Diagnos-
tic categories assigned by the research team were then
compared to categories presented by reading specialists.
Where the reading specialists assigned several competing
diagnoses to different imaged regions (e.g., the lumbar spine
versus total hip), it was assumed that the specialist’s overall
diagnosis for the patient was the one based on the lowest T-
score present. This diagnosis was then compared to the
assessment made by the research team. To assess prevalence
of standards, we report the percentage of reports that agree
with CAR diagnostic criteria.
Conformation to CAR’s 2005 reporting recommendations
Finally, collected reports were reviewed to determine their
overall conformation to CAR’s 2005 report format recom-
mendations. Specifically, the 2005 recommendations sug-
gest that all baseline reports include patient identifiers, a
DXA scanner identifier, BMD raw results (in g/cm2), T-
scores, a diagnostic category, and, for patients over age 50,
a fracture risk category. For serial scans, additional infor-
mation is suggested for inclusion: a statement as to whether
BMD change was statistically significant and the BMD test
center’s least significant change (LSC) for each skeletal site
(in g/cm2) [11].
To determine the degree to which 2008 reports con-
formed to 2005 format recommendations, the presence of
the informational elements listed above was counted in the
collected reports. Information could appear anywhere in the
reports to be counted, including in attachments from DXA
machines. A report including the brand of the DXA scanner
used met the criteria for DXA scanner identifier. It should be
noted that software programs used by scanners often pro-
vide information, such as significance of change in BMD or
diagnostic categories, by default. “Patient identifiers” were
defined as the patient’s name, date of birth, and sex.
Results
Descriptive information
Of the 267 fracture patients, a total of 103 had a BMD
scheduled or performed at the 6-month follow-up data col-
lection time point. Of these, 53 BMD reports (51 %) were
received from the referring physician. Five reports were
excluded from the present analysis because they pre-dated
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the participants’ fracture (n02), were produced by a clinic
outside of Ontario (n01), or were incomplete with only one
of two pages received (n02). This resulted in 48 BMD
reports eligible for analysis representing 27 baseline and
21 repeat scans. The 48 BMD reports were produced by a
total of 27 independent BMD scanning facilities, including
19 hospitals, between May of 2007 and October of 2008.
About one half of the scans were produced by BMD facil-
ities in small towns (<30,000 population).
The demographic characteristics of the patients repre-
sented in this sample of BMD reports are provided in
Table 1. The mean age was 67.2 years (SD±10.9 years).
Approximately three-quarters were women, and 43.8 % had
received a prior BMD test.
Fracture risk assessment review
Tables 2 and 3 summarize the results of the fracture risk
assessment review. Of the 48 reports, 42 (87.5 %)
contained a fracture risk assessment. Of note, on two
reports that did not report fracture risk, a statement was
made that fracture risk assessments were not valid for
individuals receiving treatment for osteoporosis. More-
over, of those reports that contained a fracture risk
assessment, ten (20.8 %) reported multiple fracture risks
(i.e., one for every imaged site).
On 27 of the 42 reports with a fracture risk assessment
(64.3 %), this fracture risk reflected BMD T-scores, age, and
gender, but not fracture history or other modifying factors.
These 27 reports represented 57.1 % of the repeat tests and
55.6 % of the baseline tests. Thirty-seven percent of the
baseline tests and 28.6 % of repeat tests reported a “low”
fracture risk where, given the recent fracture, “moderate”
risk was assigned by the research team. In 18.5 % of base-
line tests and 28.6 % of repeat tests, “moderate” fracture risk
was reported where “high” risk was assigned by the research
team, given the recent fracture. Fracture risk was therefore
underestimated in more than 50 % of the reports overall.
Table 3 presents a matrix relating risk assessments pro-
duced by the research team to those produced by reading
specialists. Based on this matrix, a Cohen’s kappa of 0.036
was computed, indicating the agreement between the re-
search team and the reading specialists to be poor [14]. A
linearly weighted kappa was also computed so as to penalize
disagreements spanning more than one category of risk
more than disagreements spanning only one category. In
order to compute this kappa, rows and columns
corresponding to reports with “no assessments” were ex-
cluded from Table 3. The weighted kappa was 0.21, which
lies at the margin of poor to fair agreement [15].
Diagnostic categorization review
Results from the review of diagnostic categorizations are
reported in Table 4. The majority of reports (95.8 %) in-
cluded a diagnosis. Sixteen of the 48 reports (33.3 %),
however, included a distinct diagnosis for each region
scanned.
Table 1 Demographic characteristics: patients (n048)
Characteristic Mean (SD) or N (%)
Age in years 67.2 (10.9)
Under age 50 2 (4.1 %)
Female 36 (75.0 %)
Prior BMD test 21 (43.8 %)
Table 2 Fracture risk assess-
ment review
aCalculated with modifying risk









N (%) N (%) N (%)
Reports including a risk assessment 25 (92.6) 17 (81.0) 42 (87.5)
Reports with multiple risk assessments 6 (22.2) 4 (19.0) 10 (20.8)
Risk incorporating BMD +
modifying factors
7 (25.9) 5 (23.8) 12 (25.0)
Risk incorporating BMD alone 15 (55.6) 12 (57.1) 27 (56.3)
“Moderate” riska reported
as “low”
10 (37.0) 6 (28.6) 16 (33.3)
“High” riska reported as
“moderate”
5 (18.5) 6 (28.6) 11 (22.9)
Reports for patients >50 with
no risk assessment
2 (7.4) 4 (19.1) 6 (12.5)
Reports for patients <50 with
risk assessment
1 (3.7) 0 (0.0) 1 (2.1)
Reports with explicit mention
of fracture
5 (18.5) 4 (19.1) 9 (18.8)
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Of the 26 baseline reports with a diagnosis, 18 (66.7 %)
made use of the CAR criteria. Inconsistencies with CAR
categorizations were restricted to men in the sample. Three
men (represented in two baseline and one repeat scans) were
diagnosed with osteoporosis where “reduced bone density”
was recommended; an additional six were diagnosed with
osteopenia where the same “reduced bone density” category
was advised. Two reports (one repeat and one baseline) did
not include a diagnostic category. Of note, one repeat test
mentioning menopausal status was for a man.
Conformation to CAR’s 2005 reporting recommendations
All reports included patient identifiers as well as T-scores
for imaged sites (see Table 5). Bone mineral density was
additionally reported (in raw g/cm2 units) in 85 % of base-
line and 95 % of repeat tests. Only two of the 48 reports (one
baseline and one repeat) did not include a diagnostic cate-
gorization and the majority contained a fracture risk assess-
ment, although many were inconsistent with assessments
produced by the research team as reported above. All of
the follow-up tests included a statement of BMD change
(where this change could be calculated).
Elements of reports that were less likely to be included
were scanner identifiers and LSCs detectable by scanners.
Approximately 48 % of baseline reports and 85.7 % of
repeat reports included some information on the brand of
scanners used. Approximately 44 % of baseline and 71.4 %
of repeat tests relied on attachments produced by scanning
machines to provide this information. Least significant
changes for each skeletal site were reported in only one, or
3.7 %, of the 21 repeat exams.
Discussion
The current study of 48 BMD reports from 27 independent
BMD scanning facilities in the province of Ontario aimed to
determine accuracy of 10-year fracture risk assessments
present on BMD reports in Ontario as of 2008, as well as
overall conformation to CAR’s 2005 published reporting
standards. In 2008, there were approximately 150 hospitals
in the province that were performing BMD scans (Ontario
Ministry of Health and Long-Term Care, 2011, personal
communication); our study captures data from reports pro-
duced by 19 of these, which is more than 10 % of the total.
The main finding of this study was that a minority of both
baseline and repeat reports included risk factors, namely
previous fracture, in the overall assessment of fracture risk
even though all of the patients had had a recent fracture.
This led to subsequent inaccuracies in terms of fracture risk
assessment with fracture risk being underestimated in more
than 50 % of the BMD reports. A strength of this study is
that the patients’ history of fragility fracture is based both on
records of visits to EDs as well as on interviews with an
osteoporosis coordinator. In addition, the study demonstrates
Table 3 Fracture risk assessment matrix
Reporting physician assessment Low Moderate High No risk
Research team assessment
Low 0 0 0 1
Moderate 16 3 0 2
High 2 11 9 2
No risk 0 1 0 1









N (%) N (%) N (%)
Reports including
a diagnosis
26 (0) 20 (95.2) 46 (0)
Reports with multiple
diagnoses
9 (33.3) 7 (33.3) 16 (33.3)
Reports with diagnosis
in accord with CAR
criteria




2 (7.4) 0 (0.0) 2 (4.2)
Men, T-scores <−1, >−
2.5 diagnosed with
osteopenia
5 (18.5) 1 (4.8) 6 (12.5)









N (%) N (%) N (%)
Patient identifiers
(name, DOB, sex)
27 (100.0) 21 (100.0) 48 (100.0)
Scanner identifier
(brand)
13 (48.1) 18 (85.7) 31 (64.6)
Raw BMD results
(g/cm2)
23 (85.2) 20 (95.2) 43 (89.6)
T-scores 27 (100.0) 21 (100.0) 48 (100.0)
Diagnosis 26 (96.3) 20 (95.2) 46 (95.8)
Fracture risk for
patients >50








N/A 17 (85)* N/A
Least significant change
for imaged sites
N/A 1 (4.8) N/A
*1 report could not include a statement of change due to weight gain;
% relates to remaining 20 reports
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that standards for diagnosis published by CAR in 2005 were
not regularly employed nor were recommendations for for-
matting particularly as they related to least significant detect-
able changes or scanner identification.
The fact that modifying risk factors are missed on reports
has implications not only for risk assessment, but also for
corresponding treatment recommendations. Indeed, the
most recent guidelines from Osteoporosis Canada on the
assessment of fracture risk link each of the high-,
moderate-, and low-risk assessment groups with specific
treatment recommendations/considerations [8]. Moreover,
previous research has indicated that referring physicians
actively look to BMD reports to provide these treatment
recommendations [11, 16–19]. A 1998 survey of Ontario
physicians found that suggestions for investigation and
management are among the most helpful features of BMD
reports [17]. More recently, Binkley and Krueger [16] de-
termined that over 60 % of surveyed clinicians desired
inclusion of information about fracture risk and pharmaco-
logical/nonpharmacological interventions on BMD reports
[16]. However, if reported risk assessments are inaccurate
(e.g., due to missing clinical risk factors) and are used to
inform treatment recommendations, as demonstrated in the
current study, there is the potential for inappropriate treat-
ment decisions that would leave high-risk patients untreated.
It can be argued that the individuals for whom BMD
results are perhaps most critical are those at “moderate”
fracture risk. Treatment recommendations for this group
are not straightforward [8, 20] when only BMD T-score or
clinical risk factors are available. For example, in the current
Osteoporosis Canada 2010 Guidelines for the Assessment of
Fracture Risk [8], it is recommended that for this group,
treatment should be individualized and may include phar-
macologic therapy or just basic lifestyle measures with
monitoring. It is further indicated that the moderate risk
group requires a careful evaluation to identify vertebral
fractures. In the current study, 31 % of the sample was
incorrectly classified as low risk when their risk, given
fracture history, would have been considered “moderate,”
thereby placing them in this particularly vulnerable group.
Limitations
This study had a number of limitations. Reports were gathered
from family physicians, as opposed to directly from reading
specialists. We are assuming that family physicians relayed
the BMD reports’ information precisely as it was relayed to
them, but cannot guarantee this. For example, some reports
may have contained attachments that were sent to family
doctors, but not to the research team. In addition, as the
majority of reports were produced in communities without
academic health centers, their accuracy and adherence to
standards may not reflect adherence or accuracy in other
communities. The generalizability of our results is therefore
strictly limited to BMD facilities in non-urban areas. Finally,
only 25 % of the reports were for men, and less than 5 % were
repeat reports for men. This complicates the ability to com-
prehensively assess standards and accuracy for this sub-group.
Methods used to compute fracture risk for the purpose of
this study do not align with current recommendations but
were chosen to reflect guidelines as they existed at the time
reports were produced (2008). While the research team used
the lowest T-score from the spine, total hip, or femoral neck
to assess fracture risk, 2011 recommendations are to use the
T-score from the femoral neck alone. Accuracy in assess-
ment of surveyed reports relative to the 2008 standard may
therefore be slightly different than accuracy relative to the
current standard. Moreover, the research team assumed that
risk assessments should be present on both baseline and
follow-up reports, even though some ambiguity existed in
2008 as to whether risk assessments were appropriate for
treated individuals. We note that most reports (87.5 %)
included a risk assessment, although the proportion of
follow-up reports (81.0 %) with an assessment is somewhat
lower than the proportion of baselines with an assessment
(92.6 %) potentially due, at least in part, to this ambiguity.
Summary
The current study highlights a quality gap in Ontario’s BMD
reports produced in non-urban centers of Ontario in 2008, in
which major clinical risk factors (i.e., history of recent
fracture) are not reflected in fracture risk assessments. This
has implications in terms of risk categorization and subse-
quent follow-up care and treatment recommendations par-
ticularly for fracture patients who are at moderate or high
risk for future fractures. The findings of the present study
suggest that inaccuracies in BMD reporting may result in
under-treatment of patients at high risk for future fracture.
Conflicts of interest None.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and the source are credited.
References
1. Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD (2007) Low
bone mineral density and fracture burden in postmenopausal wom-
en. CMAJ 177:575–80
904 Osteoporos Int (2013) 24:899–905
2. Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A
(2001) The burden of osteoporotic fractures: a method for setting
intervention thresholds. Osteoporos Int 12:417–427
3. Langsetmo L, Goltzman D, Kovacs CS, Adachi JD, Hanley DA,
Kreiger N, Josse R, Papaioannou A, Olszynski WP, Jamal SA,
CaMos Research Group (2009) Repeat low trauma fractures occur
frequently among men and women who have osteopenic BMD. J
Bone Miner Res 24:1515–22
4. Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren
LE, Berger ML (2004) Bone mineral density thresholds for pharmaco-
logical intervention to prevent fractures. Arch InternMed 164:1108–12
5. Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM,
Blondeau L, Berger C, Hanley DA, Prior JC, CaMos Research
Group, Canadian Multicentre Osteoporosis Study (2000) Estimation
of the prevalence of low bone density in Canadian women and men
using a population-specific DXA reference standard: the Canadian
Multicentre Osteoporosis Study (CaMos). Osteoporos Int 11:897–904
6. The North American Menopause Society (2010) Management of
osteoporosis in postmenopausal women. Menopause 17:25–54
7. Papaioannou A,Morin S, Cheung AM, Atkinson S, Brown JP, Feldman
S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski
K, Leslie WD, Scientific Advisory Council of Osteoporosis Canada
(2010) 2010 clinical practice guidelines for the diagnosis and manage-
ment of osteoporosis in Canada: summary. CMAJ 182:1864–1873
8. Lentle B, Cheung AM, Hanley DA, Leslie WD, Lyons D,
Papaioannou A, Atkinson S, Brown JP, Feldman S, Hodsman
AB, Jamal AS, Josse RG, Kaiser SM, Kvern B, Morin S,
Siminoski (2011) Osteoporosis Canada 2010 Guidelines for the
Assessment of Fracture Risk. Can Assoc Radiol J 62:243–250
9. World Health Organization. (2011) WHO fracture risk assessment
tool. http://www.shef.ac.uk/FRAX/. Accessed 15 Dec 2011.
10. Osteoporosis Canada. (2011) http://www.osteoporosis.ca.
Accessed 15 Dec 2011.
11. Siminoski K, Leslie WD, Frame H, Hodsman A, Josse RG, Khan
A, Lentle BC, Lévesque J, Lyons DJ, Tarulli G, Brown JP (2005)
Recommendations for bone mineral density reporting in Canada.
Can Assoc Radiol J 56:178–188
12. Jaglal SB, Donescu OS, Laprade J, Thorpe K, Hawker G,
Majumdar SR, Meadows L, Cadarette SM, Papaioannou,
Kloseck M, Beaton D, Bogoch E, Zwarenstein M (2011) Impact
of a centralized osteoporosis coordinator on post-fracture osteopo-
rosis management: a cluster randomized trial. Osteoporos Int
23:87–95
13. Jaglal SB, Hawker GA, Cameron C, Canavan J, Beaton DE,
Bogoch E, Jain R, Papaioannou A, ORMEW Working Group
(2010) The Ontario Osteoporosis Strategy: implementation of a
population-based osteoporosis action plan in Canada. Osteoporos
Int 21:903–908
14. Cohen J (1960) A coefficient of agreement for nominal scales.
Educ Psychol Meas 20:37–46
15. Cohen J (1968) Weighted kappa: nominal scale agreement with
provision for scale and disagreement or partial credit. Psychol Bull
70:213–220
16. Binkley N, Krueger D (2009) What should DXA reports contain?
Preferences of ordering health care providers. J Clin Densitom
12:5–10
17. Ridout R, Hawker GA (2000) Use of bone densitometry by
Ontario family physicians. Osteoporos Int 11:393–399
18. Stock JL, Waud CE, Coderre JA, Overdorf JH, Janikas JS,
Heiniluoma KM, Morris MA (1998) Clinical reporting to primary
care physicians leads to increased use and understanding of bone
densitometry and affects the management of osteoporosis. Ann
Intern Med 128:996–999
19. The Writing Group for the ISCD Position Development
Conference (2004) Indications and reporting for dual x-ray
absorptiometry. J Clin Densitom 7:37–44
20. Leslie WD, Morin S, Lix LM, Johnansson H, Oden A, McCloskey
E, Kanis JA (2012) Fracture risk assessment without bone mineral
density measurement in routine clinical practice. Osteoporos Int
23:75–85
Osteoporos Int (2013) 24:899–905 905
